Alethiomics
About:
Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.
Website: https://www.alethiomics.com
Twitter/X: Alethiomics
Top Investors: Oxford Science Enterprises
Description:
Alethiomics is a pre-clinical biotech company harnessing the power of single-cell multi-omic technology to discover and develop life-changing treatments for patients with blood cancer.
Total Funding Amount:
6M GBP
Headquarters Location:
Headington, Oxfordshire, United Kingdom
Founded Date:
2021-01-01
Contact Email:
hello(AT)alethiomics.com
Founders:
Adam Mead, Bethan Psaila
Number of Employees:
1-10
Last Funding Date:
2021-12-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai